State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

gan Chomet, Marion, van Dongen, Guus A. M. S., Vugts, Danielle J.
Cyhoeddwyd yn Bioconjug Chem (2021)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET

gan van Dongen, Guus A. M. S., Poot, Alex J., Vugts, Danielle J.
Cyhoeddwyd 2012

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

gan Pruis, Ilanah J., van Dongen, Guus A. M. S., Veldhuijzen van Zanten, Sophie E. M.
Cyhoeddwyd yn Int J Mol Sci (2020)

Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe

gan Heuveling, Derrek A., Karagozoglu, K. Hakki, Van Lingen, Arthur, Hoekstra, Otto S., Van Dongen, Guus A. M. S., De Bree, Remco
Cyhoeddwyd yn EJNMMI Res (2018)

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice

gan Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.
Cyhoeddwyd yn Theranostics (2020)

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis

gan Maussang, David, Verzijl, Dennis, van Walsum, Marijke, Leurs, Rob, Holl, Jens, Pleskoff, Olivier, Michel, Detlef, van Dongen, Guus A. M. S., Smit, Martine J.
Cyhoeddwyd 2006

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt(II) Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

gan Merkul, Eugen, Muns, Joey A., Sijbrandi, Niels J., Houthoff, Hendrik‐Jan, Nijmeijer, Bart, van Rheenen, Gerro, Reedijk, Jan, van Dongen, Guus A. M. S.
Cyhoeddwyd yn Angew Chem Int Ed Engl (2021)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

gan Perk, Lars R., Vosjan, Maria J. W. D., Visser, Gerard W. M., Budde, Marianne, Jurek, Paul, Kiefer, Garry E., van Dongen, Guus A. M. S.
Cyhoeddwyd 2009

Performance of (89)Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

gan Jauw, Yvonne W. S., Zijlstra, Josée M., de Jong, Daphne, Vugts, Danielle J., Zweegman, Sonja, Hoekstra, Otto S., van Dongen, Guus A. M. S., Huisman, Marc C.
Cyhoeddwyd yn PLoS One (2017)

Development of [(11)C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts

gan Slobbe, Paul, Windhorst, Albert D., Adamzek, Kevin, Bolijn, Marije, Schuit, Robert C., Heideman, Daniëlle A.M., van Dongen, Guus A.M.S., Poot, Alex J.
Cyhoeddwyd yn Oncotarget (2017)

High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model

gan Feroldi, Fabio, Verlaan, Mariska, Knaus, Helene, Davidoiu, Valentina, Vugts, Danielle J., van Dongen, Guus A. M. S., Molthoff, Carla F. M., de Boer, Johannes F.
Cyhoeddwyd yn Biomed Opt Express (2018)

ImmunoPET Imaging of Renal Cell Carcinoma with (124)I- and (89)Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

gan Stillebroer, Alexander B., Franssen, Gerben M., Mulders, Peter F.A., Oyen, Wim J.G., van Dongen, Guus A.M.S., Laverman, Peter, Oosterwijk, Egbert, Boerman, Otto C.
Cyhoeddwyd 2013

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice

gan Slobbe, Paul, Windhorst, Albert D, Stigter-van Walsum, Marijke, Smit, Egbert F, Niessen, Heiko G, Solca, Flavio, Stehle, Gerd, van Dongen, Guus A M S, Poot, Alex J
Cyhoeddwyd yn EJNMMI Res (2015)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlab...

gan Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle J., Guiot, Thomas, Ghanem, Ghanem, Meuleman, Nathalie, Bourgeois, Pierre, Vanderlinden, Bruno, van Dongen, Guus A. M. S., Everaert, Hendrik, Vaes, Mélanie, Bron, Dominique
Cyhoeddwyd yn Eur J Nucl Med Mol Imaging (2015)

Biodistribution, radiation dosimetry and scouting of (90)Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using (89)Zr-ibritumomab tiuxetan an...

gan Rizvi, Saiyada N. F., Visser, Otto J., Vosjan, Maria J. W. D., van Lingen, Arthur, Hoekstra, Otto S., Zijlstra, Josée M., Huijgens, Peter C., van Dongen, Guus A. M. S., Lubberink, Mark
Cyhoeddwyd 2012

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

gan Jauw, Yvonne W. S., Menke-van der Houven van Oordt, C. Willemien, Hoekstra, Otto S., Hendrikse, N. Harry, Vugts, Danielle J., Zijlstra, Josée M., Huisman, Marc C., van Dongen, Guus A. M. S.
Cyhoeddwyd yn Front Pharmacol (2016)

Facile labelling of an anti-epidermal growth factor receptor Nanobody with (68)Ga via a novel bifunctional desferal chelate for immuno-PET

gan Vosjan, Maria J. W. D., Perk, Lars R., Roovers, Rob C., Visser, Gerard W. M., Stigter-van Walsum, Marijke, van Bergen en Henegouwen, Paul M. P., van Dongen, Guus A. M. S.
Cyhoeddwyd 2011

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

gan Tijink, Bernard M., Perk, Lars R., Budde, Marianne, Stigter-van Walsum, Marijke, Visser, Gerard W. M., Kloet, Reina W., Dinkelborg, Ludger M., Leemans, C. René, Neri, Dario, van Dongen, Guus A. M. S.
Cyhoeddwyd 2009

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

gan Gaillard, Pieter J., Appeldoorn, Chantal C. M., Dorland, Rick, van Kregten, Joan, Manca, Francesca, Vugts, Danielle J., Windhorst, Bert, van Dongen, Guus A. M. S., de Vries, Helga E., Maussang, David, van Tellingen, Olaf
Cyhoeddwyd 2014

Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)Zr-immuno-PET

gan Vugts, Danielle J., Klaver, Chris, Sewing, Claudia, Poot, Alex J., Adamzek, Kevin, Huegli, Seraina, Mari, Cristina, Visser, Gerard W. M., Valverde, Ibai E., Gasser, Gilles, Mindt, Thomas L., van Dongen, Guus A. M. S.
Cyhoeddwyd yn Eur J Nucl Med Mol Imaging (2016)